• Investment World
• eWorld
• Catalyst
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• The Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Hyderabad , Jan. 18

AUROBINDO Pharma Ltd has announced that the World Health Organisation, Geneva, has included two more of its anti-retroviral drugs - Nevirapine oral suspension 50 mg/5 ml and Stavudine oral solution 1 mg/ml - in the pre-qualification list.

In a press release here on Wednesday, the company said this inclusion takes the count of the company's products in the pre-qualification list to 12.

Further, the company said this is the first time that a generic version of Nevirapine oral suspension has been included in the pre-qualification list.

More Stories on : Announcements

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Dutch co to supply mooring, allied systems to Kochi Refineries

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line